Real-World Clinical Outcomes in Relapsing-Remitting Multiple Sclerosis Patients who Switch from Natalizumab to Delayed-Release Dimethyl Fumarate: A Multicenter, Retrospective, Observational Study (STRATEGY) (P3.293)

Stanley Cohan; Jonathan Calkwood; Christopher LaGanke; Carlo Tornatore; Harold Moses; Kyle Smoot; Monica Mann; Ven Meka; Macaulay Okwuokenye; Christophe Hotermans; Leslie Meltzer
{'id': 'https://openalex.org/W2255875569', 'doi': 'https://doi.org/10.1212/wnl.84.14_supplement.p3.293', 'title': 'Real-World Clinical Outcomes in Relapsing-Remitting Multiple Sclerosis Patients who Switch from Natalizumab to Delayed-Release Dimethyl Fumarate: A Multicenter, Retrospective, Observational Study (STRATEGY) (P3.293)', 'display_name': 'Real-World Clinical Outcomes in Relapsing-Remitting Multiple Sclerosis Patients who Switch from Natalizumab to Delayed-Release Dimethyl Fumarate: A Multicenter, Retrospective, Observational Study (STRATEGY) (P3.293)', 'publication_year': 2015, 'publication_date': '2015-04-06', 'ids': {'openalex': 'https://openalex.org/W2255875569', 'doi': 'https://doi.org/10.1212/wnl.84.14_supplement.p3.293', 'mag': '2255875569'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1212/wnl.84.14_supplement.p3.293', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S79704628', 'display_name': 'Neurology', 'issn_l': '0028-3878', 'issn': ['0028-3878', '1526-632X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5067317369', 'display_name': 'Stanley Cohan', 'orcid': 'https://orcid.org/0000-0002-9568-346X'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Stanley Cohan', 'raw_affiliation_strings': ['Providence Multiple Sclerosis Center Portland OR United States'], 'affiliations': [{'raw_affiliation_string': 'Providence Multiple Sclerosis Center Portland OR United States', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5004241893', 'display_name': 'Jonathan Calkwood', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jonathan Calkwood', 'raw_affiliation_strings': ['Schapiro Center for Multiple Sclerosis Minneapolis MN United States'], 'affiliations': [{'raw_affiliation_string': 'Schapiro Center for Multiple Sclerosis Minneapolis MN United States', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076958249', 'display_name': 'Christopher LaGanke', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210099869', 'display_name': 'Urology Associates', 'ror': 'https://ror.org/011krwa35', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210099869']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christopher LaGanke', 'raw_affiliation_strings': ['North Central Neurology Associates, PC Cullman AL United States'], 'affiliations': [{'raw_affiliation_string': 'North Central Neurology Associates, PC Cullman AL United States', 'institution_ids': ['https://openalex.org/I4210099869']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5107948205', 'display_name': 'Carlo Tornatore', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2802534011', 'display_name': 'MedStar Georgetown University Hospital', 'ror': 'https://ror.org/03ja1ak26', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802534011', 'https://openalex.org/I86755215']}, {'id': 'https://openalex.org/I184565670', 'display_name': 'Georgetown University', 'ror': 'https://ror.org/05vzafd60', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I184565670']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Carlo Tornatore', 'raw_affiliation_strings': ['Department of Neurology, Medstar Georgetown University Hospital Washington DC United States'], 'affiliations': [{'raw_affiliation_string': 'Department of Neurology, Medstar Georgetown University Hospital Washington DC United States', 'institution_ids': ['https://openalex.org/I2802534011', 'https://openalex.org/I184565670']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111535783', 'display_name': 'Harold Moses', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I901861585', 'display_name': 'Vanderbilt University Medical Center', 'ror': 'https://ror.org/05dq2gs74', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210162197', 'https://openalex.org/I901861585']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Harold Moses', 'raw_affiliation_strings': ['Department of Neurology, Neuroimmunology Division, Vanderbilt University Medical Center Nashville TN United States'], 'affiliations': [{'raw_affiliation_string': 'Department of Neurology, Neuroimmunology Division, Vanderbilt University Medical Center Nashville TN United States', 'institution_ids': ['https://openalex.org/I901861585']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112702997', 'display_name': 'Kyle Smoot', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kyle Smoot', 'raw_affiliation_strings': ['Providence Multiple Sclerosis Center Portland OR United States'], 'affiliations': [{'raw_affiliation_string': 'Providence Multiple Sclerosis Center Portland OR United States', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112136765', 'display_name': 'Monica Mann', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1297540436', 'display_name': 'Biogen (United States)', 'ror': 'https://ror.org/02jqkb192', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1297540436']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Monica Mann', 'raw_affiliation_strings': ['Biogen Idec Weston MA United States'], 'affiliations': [{'raw_affiliation_string': 'Biogen Idec Weston MA United States', 'institution_ids': ['https://openalex.org/I1297540436']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5088683909', 'display_name': 'Ven Meka', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1297540436', 'display_name': 'Biogen (United States)', 'ror': 'https://ror.org/02jqkb192', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1297540436']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ven Meka', 'raw_affiliation_strings': ['Biogen Idec Cambridge MA United States'], 'affiliations': [{'raw_affiliation_string': 'Biogen Idec Cambridge MA United States', 'institution_ids': ['https://openalex.org/I1297540436']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5037249165', 'display_name': 'Macaulay Okwuokenye', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1297540436', 'display_name': 'Biogen (United States)', 'ror': 'https://ror.org/02jqkb192', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1297540436']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Macaulay Okwuokenye', 'raw_affiliation_strings': ['Biogen Idec Cambridge MA United States'], 'affiliations': [{'raw_affiliation_string': 'Biogen Idec Cambridge MA United States', 'institution_ids': ['https://openalex.org/I1297540436']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021855649', 'display_name': 'Christophe Hotermans', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1297540436', 'display_name': 'Biogen (United States)', 'ror': 'https://ror.org/02jqkb192', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1297540436']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christophe Hotermans', 'raw_affiliation_strings': ['Biogen Idec Weston MA United States'], 'affiliations': [{'raw_affiliation_string': 'Biogen Idec Weston MA United States', 'institution_ids': ['https://openalex.org/I1297540436']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5110345890', 'display_name': 'Leslie Meltzer', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1297540436', 'display_name': 'Biogen (United States)', 'ror': 'https://ror.org/02jqkb192', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1297540436']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Leslie Meltzer', 'raw_affiliation_strings': ['Biogen Idec Weston MA United States'], 'affiliations': [{'raw_affiliation_string': 'Biogen Idec Weston MA United States', 'institution_ids': ['https://openalex.org/I1297540436']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 5, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.157, 'has_fulltext': False, 'cited_by_count': 6, 'citation_normalized_percentile': {'value': 0.624288, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 82, 'max': 83}, 'biblio': {'volume': '84', 'issue': '14_supplement', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10137', 'display_name': 'Multiple Sclerosis Research Studies', 'score': 0.9881, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10137', 'display_name': 'Multiple Sclerosis Research Studies', 'score': 0.9881, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11827', 'display_name': 'Polyomavirus and related diseases', 'score': 0.9767, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10950', 'display_name': 'Acute Lymphoblastic Leukemia research', 'score': 0.948, 'subfield': {'id': 'https://openalex.org/subfields/2739', 'display_name': 'Public Health, Environmental and Occupational Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/natalizumab', 'display_name': 'Natalizumab', 'score': 0.9779966}, {'id': 'https://openalex.org/keywords/dimethyl-fumarate', 'display_name': 'Dimethyl fumarate', 'score': 0.9101698}, {'id': 'https://openalex.org/keywords/relapsing-remitting', 'display_name': 'Relapsing remitting', 'score': 0.81451905}], 'concepts': [{'id': 'https://openalex.org/C2781004633', 'wikidata': 'https://www.wikidata.org/wiki/Q386119', 'display_name': 'Natalizumab', 'level': 3, 'score': 0.9779966}, {'id': 'https://openalex.org/C2776819417', 'wikidata': 'https://www.wikidata.org/wiki/Q418123', 'display_name': 'Dimethyl fumarate', 'level': 3, 'score': 0.9101698}, {'id': 'https://openalex.org/C2780640218', 'wikidata': 'https://www.wikidata.org/wiki/Q8277', 'display_name': 'Multiple sclerosis', 'level': 2, 'score': 0.8313123}, {'id': 'https://openalex.org/C3020694758', 'wikidata': 'https://www.wikidata.org/wiki/Q42417392', 'display_name': 'Relapsing remitting', 'level': 3, 'score': 0.81451905}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.73649687}, {'id': 'https://openalex.org/C23131810', 'wikidata': 'https://www.wikidata.org/wiki/Q818574', 'display_name': 'Observational study', 'level': 2, 'score': 0.7203208}, {'id': 'https://openalex.org/C167135981', 'wikidata': 'https://www.wikidata.org/wiki/Q2146302', 'display_name': 'Retrospective cohort study', 'level': 2, 'score': 0.49645478}, {'id': 'https://openalex.org/C2992435398', 'wikidata': 'https://www.wikidata.org/wiki/Q6934595', 'display_name': 'Multicenter study', 'level': 3, 'score': 0.4762835}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3674026}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.21322772}, {'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.1173974}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1212/wnl.84.14_supplement.p3.293', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S79704628', 'display_name': 'Neurology', 'issn_l': '0028-3878', 'issn': ['0028-3878', '1526-632X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4311483557', 'https://openalex.org/W4292707405', 'https://openalex.org/W4238977932', 'https://openalex.org/W4236340714', 'https://openalex.org/W3090279788', 'https://openalex.org/W3016997033', 'https://openalex.org/W3000377904', 'https://openalex.org/W2792091596', 'https://openalex.org/W2343984847', 'https://openalex.org/W2151867003'], 'abstract_inverted_index': {'OBJECTIVE:': [0], 'Describe': [1], 'a': [2, 106, 381, 433], 'retrospective': [3], 'observational': [4], 'study': [5, 115], 'of': [6, 55, 88, 145, 154, 158, 173, 189, 194, 201, 208, 271], 'relapsing-remitting': [7], 'multiple': [8], 'sclerosis': [9], '(RRMS)': [10], 'patients': [11, 75, 121, 195, 202, 209, 278], 'who': [12, 279], 'switched': [13, 280], 'from': [14, 57, 76, 122, 281], 'natalizumab': [15, 49, 58, 77, 95, 149, 222, 226], 'to': [16, 38, 47, 59, 78, 152, 165, 170, 220, 267, 274], 'delayed-release': [17], 'dimethyl': [18], 'fumarate': [19], '(DMF;': [20], 'also': [21], 'known': [22], 'as': [23, 192, 328, 380, 432, 446, 460, 474, 488, 503], 'gastro-resistant': [24], 'DMF)': [25], 'in': [26, 276], 'the': [27, 247], 'real-world': [28], 'setting.': [29], 'Factors': [30], 'potentially': [31], 'associated': [32], 'with': [33, 148, 203, 210, 299, 314, 342, 373, 395, 419, 443, 457, 471, 485, 499], 'treatment': [34, 63, 90, 147, 272], 'outcomes': [35, 91], 'on': [36, 52, 70, 92, 225, 230, 239, 254], 'DMF': [37, 93, 159, 175, 190, 275], 'be': [39, 128, 180, 261], 'included': [40], 'are': [41, 96, 168], 'patient': [42], 'demographics,': [43], 'disease': [44, 217], 'activity': [45, 184, 218, 229, 238, 252], 'prior': [46, 151, 164, 219], 'initiating': [48, 221], 'or': [50, 117, 223], 'while': [51, 224, 253], 'natalizumab,': [53], 'duration': [54, 235], 'washout': [56, 234, 248], 'DMF,': [60, 155], 'and': [61, 82, 86, 156, 206, 227, 236, 241, 250, 304, 326, 363, 378, 409, 429], 'steroid': [62, 244], 'during': [64, 246], 'washout.\nBACKGROUND:': [65], 'There': [66], 'is': [67, 102, 257, 264], 'limited': [68], 'information': [69], 'standardized': [71], 'practices': [72, 81], 'for': [73, 297, 312, 340, 371, 393, 417, 441, 455, 469, 483, 497], 'transitioning': [74], 'DMF.': [79], 'Clinical': [80], 'switch': [83], 'protocols': [84], 'vary,': [85], 'predictors': [87, 270], 'favorable': [89], 'following': [94], 'not': [97], 'well': [98], 'understood.': [99], 'DESIGN/METHODS:': [100], 'STRATEGY': [101, 256, 263], 'being': [103, 265], 'performed': [104], 'through': [105], 'single': [107], 'time': [108], 'point': [109], 'medical': [110], 'chart': [111], 'abstraction': [112], 'without': [113], 'required': [114], 'visits': [116], 'procedures.': [118], 'Approximately': [119], '500−700': [120], 'approximately': [123], '50': [124], 'US': [125], 'sites': [126], 'will': [127, 179, 260], 'enrolled.': [129], 'Key': [130], 'inclusion': [131], 'criteria': [132], 'include': [133], 'age': [134], '蠅18': [135], 'years,': [136], 'RRMS': [137, 277], 'diagnosis': [138], '(McDonald': [139], 'criteria),': [140], 'at': [141, 160], 'least': [142, 161], '12': [143, 162, 185], 'months': [144, 163, 186], 'continuous': [146], 'monotherapy': [150], 'initiation': [153, 157, 188], 'enrollment.': [166], 'Patients': [167], 'eligible': [169], 'enroll': [171], 'regardless': [172], 'current': [174], 'use.': [176], 'Multiple': [177], 'endpoints': [178], 'examined,': [181], 'including': [182], 'relapse': [183, 198, 228, 237, 251], 'after': [187], '(measured': [191], 'proportion': [193, 200, 207], 'relapsed,': [196], 'annualized': [197], 'rate,': [199], 'MS-related': [204], 'hospitalization,': [205], 'relapses': [211], 'requiring': [212], 'intravenous': [213], 'steroids);': [214], 'association': [215, 232, 242], 'between': [216, 233, 243], 'DMF;': [231, 240], 'use': [245], 'period': [249], 'DMF.\nRESULTS:': [255], 'ongoing;': [258], 'results': [259], 'reported.\nCONCLUSIONS:': [262], 'conducted': [266], 'examine': [268], 'potential': [269], 'response': [273], 'natalizumab.\nStudy': [282], 'Supported': [283], 'by:': [284], 'Biogen': [285, 301, 319, 348, 374, 400, 422, 444, 458, 472, 486, 500], 'Idec': [286, 445, 459, 473, 487], 'Disclosure:': [289], 'Dr.': [291, 306, 334, 366, 387, 412, 435, 449, 463, 477, 491], 'Cohan': [292], 'has': [293, 308, 336, 368, 389, 414, 437, 451, 465, 479, 493], 'received': [294, 309, 337, 390, 438, 452, 466, 480, 494], 'personal': [295, 310, 338, 369, 391, 415, 439, 453, 467, 481, 495], 'compensation': [296, 311, 339, 370, 392, 416, 440, 454, 468, 482, 496], 'activities': [298, 313, 341, 372, 394, 418, 442, 456, 470, 484, 498], 'Acorda,': [300], 'Idec,': [302, 320, 349, 375, 401, 423, 501], 'Novartis,': [303, 324, 353, 404, 428], 'Sanofi.': [305], 'Calkwood': [307], 'Acorda': [315, 343, 410, 420], 'Therapeutics,': [316, 344, 421], 'Bayer': [317, 345, 402], 'Healthcare,': [318], 'EMD': [321, 350, 396, 424], 'Serono,': [322, 351, 397, 425], 'Genzyme,': [323, 408], 'Questcor,': [325, 405], 'Teva': [327, 361, 398, 430], 'an': [329, 447, 461, 475, 489, 504], 'advisor,': [330], 'consultant,': [331], 'and/or': [332, 383], 'speaker.': [333], 'LaGanke': [335], 'Pharmaceuticals': [346], 'Corp.,': [347, 360], 'Pfizer': [354, 426], 'Inc.,': [355, 427], 'Questcor': [357], 'Diagnostics,': [358], 'Genzyme': [359, 376], 'Neuroscience,': [362, 399], 'UCB': [364], 'Pharma.': [365], 'Tornatore': [367], 'Corporation,': [377], 'Novartis': [379], 'consultant': [382], 'speakers': [384], 'bureau': [385], 'member.': [386], 'Moses': [388], 'Pharmaceuticals,': [403], 'Actelion,': [407], 'Therapeutics.': [411], 'Smoot': [413], 'Neuroscience': [431], 'consultant.': [434], 'Mann': [436], 'employee.': [448, 462, 476, 490, 505], 'Meka': [450], 'Okwuokenye': [464], 'Hotermans': [478], 'Meltzer': [492], 'Inc.': [502]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2255875569', 'counts_by_year': [{'year': 2019, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 4}, {'year': 2015, 'cited_by_count': 1}], 'updated_date': '2024-12-16T11:27:53.514156', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
